Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Mankind Pharma consolidated net profit rises 31.75% in the March 2026 quarter
Sales rise 11.81% to Rs 3442.93 crore
Stocks to Watch Today: Hindalco, AB Capital, ASK Automotive, Dredging Corp, PTC India, Mankind Pharma,... - Moneycontrol.com
Stocks to Watch Today: Hindalco, AB Capital, ASK Automotive, Dredging Corp, PTC India, Mankind Pharma,...Moneycontrol.com
Mankind Pharma profit jumps 30% on chronic therapy demand in Q4
Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chronic therapies and consumer healthcare products. The company's domestic formulations business is showing a revival. Improved sales execution and the successful integration of Bharat Serums and Vaccines contributed to this positive performance.
Mankind Pharma Q4 revenue rises 12%; chronic therapies drive margin expansion
Mankind Pharma reported strong fourth-quarter operating performance driven by healthy domestic demand, chronic therapy growth and improved margins, while international business growth remained muted amid geopolitical challenges.
Stocks to Watch for May 20: BPCL, Mankind Pharma, Orkla India, PI Industries and more
BPCL profit slumps on exceptional loss, while Orkla India, Godawari Power and Karnataka Bank report strong earnings growth. PTC India’s profit declines sharply, and JSW Energy moves to raise its stake in Toshiba JSW. Here are the stocks to watch ahead of Wednesday’s trading session.
Mankind Pharma Q4 Result: Net Profit Rises 32%, Margins Expand
Consolidate revenue of Mankind Pharma advanced by 11.8% year-on-year for the three months ended March, reaching Rs 3,443 crore in comparison to Rs 3,079 crore.
Q4 Results Live Updates: Eureka Forbes Profit Flat; Dhanuka Agritech Announces Share Buyback
BEL, BPCL, Mankind Pharma are among companies set to report earnings today.
Bharat Electronics, BPCL, Mankind Pharma, Zee Entertainment, Zydus Lifesciences Q4 Results Today — Earning Estimates
BPCL is expected to report March-quarter earnings with standalone revenue at Rs 1,17,692.16 crore.
Mankind Pharma Ltd rises for third straight session
Mankind Pharma Ltd is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The stock is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty Pharma index.
Mankind Pharma Ltd up for fifth session
Mankind Pharma Ltd is quoting at Rs 2439.2, up 2.69% on the day as on 12:44 IST on the NSE. The stock is up 1.29% in last one year as compared to a 0.65% spurt in NIFTY and a 14.52% spurt in the Nifty Pharma.
Stock Picks Today: Bharat Forge, CarTrade, Westlife Food, Mankind Pharma And More On Brokerages' Radar
Check out the top stocks on brokerages' radar heading into trade today.
Mankind Pharma Ltd spurts 1.46%, up for third straight session
Mankind Pharma Ltd is quoting at Rs 2353.3, up 1.46% on the day as on 12:49 IST on the NSE. The stock is down 3.25% in last one year as compared to a 1.62% fall in NIFTY and a 12.19% fall in the Nifty Pharma index.